INDOCO REMEDIES LTD. - 532612 - Unaudited Financial Results
Unaudited financial results for the quarter ended 31.12.202009-02-2021
09-02-2021
INDOCO REMEDIES LTD. - 532612 - Announcement Under Reg 30 (LODR) Updates
Schedule of con call meeting22-01-2021
Indoco Remedies Q3 PAT seen up 191.2% YoY to Rs. 9.3 cr: Prabhudas Lilladher
Net Sales are expected to increase by 17.7 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 283.4 crore, according to Prabhudas Lilladher.18-01-2021
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Board Meeting Notice14-01-2021
INDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December, 31, 2020
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December, 31, 202013-01-2021
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended December 31, 2020
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here07-01-2021
INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CERTIFICATE UNDER REG 74(5)07-01-2021
INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAYSHANKAR MENONDesignation :- Company Secretary and Compliance Officer07-01-2021
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst Meet05-01-2021
INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
Closure of Trading window from Friday, January, 01, 2021 until 48 hours after the declaration of Unaudited Financial Results for the third quarter ended December 31, 2020.31-12-2020